v3.19.3
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Current assets    
Cash and cash equivalents $ 178,891 $ 9,811
Accounts receivable, net 91,133 76,919
Inventories 12,632 8,650
Prepaid assets 8,742 7,727
Other current assets 603 561
Total current assets 292,001 103,668
Property and equipment (net of accumulated depreciation of $64,165 and $50,127, respectively) 62,488 60,888
Operating lease right-of-use assets 25,797  
Intangible assets, net 129,084 140,029
Goodwill 198,571 197,892
Other assets 3,214 2,538
Total assets 711,155 505,015
Current liabilities    
Accounts payable 17,995 17,779
Accrued compensation 26,298 19,062
Accrued expenses and other liabilities 7,900 8,986
Short-term portion of financing obligations 5,750  
Short-term portion of financing obligations   6,298
Short-term portion of operating leases 3,527  
Short-term portion of term loan 6,250 7,873
Pharma contract liability 1,187 927
Total current liabilities 68,907 60,925
Long-term liabilities    
Long-term portion of finance lease obligations 3,982  
Long-term portion of finance lease obligations   5,250
Long-term portion of operating leases 23,870  
Long-term portion of term loan, net 93,027 87,880
Revolving credit facility 0 5,000
Other long term liabilities 4,674 3,060
Deferred income tax liability, net 19,688 22,457
Total long-term liabilities 145,241 123,647
Total liabilities 214,148 184,572
Stockholders' equity    
Common stock, $0.001 par value, (250,000,000 shares authorized; 104,145,895 and 94,465,440 shares issued and outstanding, respectively) 104 94
Additional paid-in capital 516,936 340,291
Accumulated other comprehensive loss (2,380) (579)
Accumulated deficit (17,653) (19,363)
Total stockholders’ equity 497,007 320,443
Total liabilities and stockholders' equity $ 711,155 $ 505,015

Source